Here's what sets us apart: Expert Guidance: Our experienced medical providers specialize in peptide therapy and are dedicated to helping you achieve your health and wellness goals
[DOI] [PMC free article] [PubMed] [Google Scholar] Mki JM, Rsnen J, Tikkanen H, Sormunen R, Mkikallio K, Kivirikko KI, Soininen R (2002) Inactivation of the lysyl oxidase gene lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice
Ig Sanita Pubbl 80(4):130134 Garcia-Bello JA, Gmez-Daz RA, Contreras-Rodrguez A, Talavera JO et al (2014) Carotid intima media thickness, oxidative stress, and inflammation in children with chronic kidney disease
The peptides frequently being referenced in reclassification conversations include: AOD-9604 BPC-157 Emideltide (DSIP Delta Sleep-Inducing Peptide) Epitalon (Epithalamin) GHK-Cu (Copper Peptide) Kisspeptin-10 KPV MOTS-C Semax Selank TB-500 (Thymosin Beta-4 Fragment) Thymosin Alpha-1 Despite public discussion, these peptides remain categorized as Category 2 under current FDA policy and are not eligible for patient-specific 503A compounding
